EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trolox, r-irisin and resveratrol cocktail to counteract osteoblast metabolism alterations in osteoarthritis and osteoporosis

Roberto Bonanni, Angela Falvino, Amarildo Smakaj, Lucia Tranquillo, Anna Maria Rinaldi, Giovanna D'Arcangelo, Pierangelo Cifelli, Virginia Tancredi, Ida Cariati, Umberto Tarantino

Journal of Bone and Mineral Metabolism · 2025-11 · 43 (6) · 672-684

DOI: 10.1007/s00774-025-01642-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Mineral Metabolism, online erschienen am 16.09.2025. Verfasst von Roberto Bonanni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Hauptthemen laut MEDLINE: Resveratrol, Osteoporosis, Osteoarthritis, Osteoblasts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Ministero dell’Istruzione, dell’Università e della Ricerca, Università degli Studi di Roma Tor Vergata.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Osteoarthritis and osteoporosis are age-related musculoskeletal disorders characterized by increased oxidative stress and cellular senescence, which contribute to altered metabolism and disease progression. Although research in this field is constantly evolving, the discovery of new molecular targets and drug combinations to counteract musculoskeletal disorders remains a goal of great interest. This study aimed to evaluate the efficacy of a cocktail of trolox, recombinant irisin (r-irisin) and resveratrol in modulation of osteoblastic metabolism by investigating the expression of NADPH oxidase 4 (NOX4), sirtuin 1 (SIRT1) and pentraxin 3 (PTX3). Materials and methods 20 male patients undergoing hip arthroplasty were enrolled, including ten patients with coxarthrosis and ten patients with osteoporosis. Femoral head biopsies were taken from each patient to isolate primary osteoblast cultures, which were treated with the cocktail for 6 days.

Results

The cocktail of trolox, r-irisin and resveratrol increased cell viability, and reduced ROS and senescence β-galactosidase activity (SA-β-Gal) levels. In addition, western blotting analysis showed reduced expression of NOX4 and increased expression of SIRT1 and PTX3 in both experimental groups, although with more pronounced effects in osteoarthritic patients, highlighting lower treatment efficacy in the presence of osteoporosis.

Conclusions

The improvement in cell viability and reduction in oxidative stress and cellular senescence observed through treatment-induced modulation of the NOX4–SIRT1 axis and PTX3 suggests a protective role for these biomarkers in bone metabolism. These findings could offer new perspectives in counteracting the effects of aging on the skeletal system by improving bone health and mitigating metabolic alterations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolOsteoporosisOsteoarthritisOsteoblastsChromansFibronectinsHumansMaleSirtuin 1AgedC-Reactive ProteinMiddle AgedSerum Amyloid P-ComponentNADPH Oxidase 4Cell SurvivalReactive Oxygen SpeciesCellular SenescencePentraxins

Stichwörter der Autor:innen

Bone metabolismMusculoskeletal agingOsteoarthritisOsteoporosisPhysiology

Substanzen

ResveratrolSirtuin 1ChromansFibronectinsC-Reactive ProteinSerum Amyloid P-ComponentNADPH Oxidase 4Reactive Oxygen SpeciesPentraxins6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid

Autor:innen und Institutionen

  • Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Department of Biomedicine and Prevention, "Tor Vergata" University of Rome, Rome, Italy.
  • Department of Orthopaedics and Traumatology, "Policlinico Tor Vergata" Foundation, Rome, Italy.
  • Department of Systems Medicine, "Tor Vergata" University of Rome, Rome, Italy.
  • Centre of Space Bio-Medicine, "Tor Vergata" University of Rome, Rome, Italy.
  • Department of Systems Medicine, "Tor Vergata" University of Rome, Rome, Italy. ida.cariati@uniroma2.it.

Förderung

  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Università degli Studi di Roma Tor Vergata

Zitieren

APA

Bonanni, R., Falvino, A., Smakaj, A., Tranquillo, L., Rinaldi, A. M., D'Arcangelo, G., Cifelli, P., Tancredi, V., Cariati, I., & Tarantino, U. (2025). Trolox, r-irisin and resveratrol cocktail to counteract osteoblast metabolism alterations in osteoarthritis and osteoporosis. Journal of Bone and Mineral Metabolism, 43(6), 672-684. https://doi.org/10.1007/s00774-025-01642-7

Vancouver

Bonanni R, Falvino A, Smakaj A, Tranquillo L, Rinaldi AM, D'Arcangelo G, et al. Trolox, r-irisin and resveratrol cocktail to counteract osteoblast metabolism alterations in osteoarthritis and osteoporosis. Journal of Bone and Mineral Metabolism. 2025;43(6):672-684. doi:10.1007/s00774-025-01642-7

BibTeX
@article{Bonanni2025,
  author = {Bonanni, Roberto and Falvino, Angela and Smakaj, Amarildo and Tranquillo, Lucia and Rinaldi, Anna Maria and D'Arcangelo, Giovanna and Cifelli, Pierangelo and Tancredi, Virginia and Cariati, Ida and Tarantino, Umberto},
  title = {Trolox, r-irisin and resveratrol cocktail to counteract osteoblast metabolism alterations in osteoarthritis and osteoporosis},
  journal = {Journal of Bone and Mineral Metabolism},
  year = {2025},
  volume = {43},
  number = {6},
  pages = {672--684},
  doi = {10.1007/s00774-025-01642-7}
}
Kostenlos starten →